Literature DB >> 21979865

Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement.

Frank Donnerstag1, Xiaoqi Ding, Lars Pape, Eva Bültmann, Thomas Lücke, Jan Zajaczek, Ludwig Hoy, Anibh Martin Das, Heinrich Lanfermann, Jochen Ehrich, Hans Hartmann.   

Abstract

OBJECTIVES: Diffusion-weighted imaging (DWI) in children with diarrhoea associated haemolytic uraemic syndrome (D+HUS) and cerebral involvement was evaluated retrospectively.
METHODS: DWI within 24 h of onset of neurological symptoms. The apparent diffusion coefficient (ADC) was measured in grey/white matter and correlated with clinical and laboratory findings.
RESULTS: DWI was abnormal in all. Abnormal ADC was detected in the supratentorial white matter (6/12) and cortex (1/12), the basal ganglia (5/12), the thalami (4/12), and the cerebellum (1/12). ADC was reduced in 5/12, increased in 4/12, and both in 3/12. Mean serum sodium was lower in patients with DWI abnormalities affecting the white matter (6/12), than in those with basal ganglia/thalamic involvement (6/12). Neurological outcome was normal in 4/11 and abnormal in 7/11, and 1 patient died, outcome did not correlate to either localisation or type of DWI abnormality.
CONCLUSIONS: In D+HUS with neurological symptoms, early DWI may reveal abnormal ADC not only in the basal ganglia/thalami, but also in the white matter/cortex. Besides thrombotic microangiopathy, toxic effects of shiga toxin, azotaemia and hyponatraemia / hypoosmolality may be involved in cerebral involvement in children with D+HUS. Findings on early MRI seem not to predict clinical course or outcome. KEY POINTS: • DWI MR imaging may detect early CNS involvement in haemolytic uraemic syndrome • Different pathogenetical mechanisms may contribute to the CNS disease in HUS • Early MRI findings do not seem to allow prediction of clinical outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21979865     DOI: 10.1007/s00330-011-2286-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  36 in total

1.  Encephalopathy and exposure to Shiga toxin without evidence of haemolytic uraemic syndrome.

Authors:  Frank Ahrens; Kerstin Ludwig; Klaus Terstegge; Uwe Querfeld
Journal:  Eur J Pediatr       Date:  2002-08       Impact factor: 3.183

2.  A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging.

Authors:  C L Chen; P H Lai; K J Chou; P T Lee; H M Chung; H C Fang
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

3.  Central nervous system involvement in a child with hemolytic uremic syndrome.

Authors:  E Signorini; S Lucchi; M Mastrangelo; S Rapuzzi; A Edefonti; E Fossali
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

4.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

5.  Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.

Authors:  Patricia B Eisenhauer; Mary S Jacewicz; Kelly J Conn; Omanand Koul; John M Wells; Richard E Fine; David S Newburg
Journal:  Microb Pathog       Date:  2004-04       Impact factor: 3.738

6.  The hemolytic-uremic syndrome: prognostic significance of neurological abnormalities.

Authors:  A P Bos; R A Donckerwolcke; A J van Vught
Journal:  Helv Paediatr Acta       Date:  1985-12

7.  Escherichia coli O-157-induced hemolytic uremic syndrome: Usefulness of SCWP score for the prediction of neurological complication.

Authors:  Takahide Teramoto; Toshiyuki Fukao; Kouichiro Hirayama; Tsutomu Asano; Yusuke Aoki; Naomi Kondo
Journal:  Pediatr Int       Date:  2009-02       Impact factor: 1.524

8.  CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.

Authors:  J F Bale; C Brasher; R L Siegler
Journal:  Am J Dis Child       Date:  1980-09

9.  Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy.

Authors:  H Ogura; M Takaoka; M Kishi; M Kimoto; T Shimazu; T Yoshioka; H Sugimoto
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

Review 10.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

View more
  15 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

2.  Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.

Authors:  Lucas Percheron; Raluca Gramada; Stéphanie Tellier; Remi Salomon; Jérôme Harambat; Brigitte Llanas; Marc Fila; Emma Allain-Launay; Anne-Laure Lapeyraque; Valerie Leroy; Anne-Laure Adra; Etienne Bérard; Guylhène Bourdat-Michel; Hassid Chehade; Philippe Eckart; Elodie Merieau; Christine Piètrement; Anne-Laure Sellier-Leclerc; Véronique Frémeaux-Bacchi; Chloe Dimeglio; Arnaud Garnier
Journal:  Pediatr Nephrol       Date:  2018-03-23       Impact factor: 3.714

3.  Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome.

Authors:  Kathrin Buder; Beatrice Latal; Samuel Nef; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2014-09-19       Impact factor: 3.714

4.  Unilateral motor weakness with kidney failure: Answers.

Authors:  Ryutaro Suzuki; Mai Sato; Masao Ogura; Yuka Murofushi; Yuichi Abe; Koichi Kamei
Journal:  Pediatr Nephrol       Date:  2021-09-09       Impact factor: 3.714

5.  Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI.

Authors:  Karin Weissenborn; Eva Bültmann; Frank Donnerstag; Anja M Giesemann; Friedrich Götz; Hans Worthmann; Meike Heeren; Jan Kielstein; Anke Schwarz; Heinrich Lanfermann; Xiao-Qi Ding
Journal:  Neuroradiology       Date:  2013-04-05       Impact factor: 2.804

6.  Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.

Authors:  Angela Bauer; Sebastian Loos; Carola Wehrmann; Dirk Horstmann; Frank Donnerstag; Johanna Lemke; Georg Hillebrand; Ulrike Löbel; Lars Pape; Dieter Haffner; Carola Bindt; Thurid Ahlenstiel; Anette Melk; Anja Lehnhardt; Markus J Kemper; Jun Oh; Hans Hartmann
Journal:  Pediatr Nephrol       Date:  2014-03-25       Impact factor: 3.714

7.  Steroid Pulse Therapy for Severe Central Nervous System Involvement in Shiga Toxin-Producing Escherichia coli-Related Hemolytic Uremic Syndrome.

Authors:  Chiara Rosazza; Alberto M Cappellari; Cristiano Gandini; Elisa Scola; Gianluigi Ardissino
Journal:  Case Rep Pediatr       Date:  2021-05-15

8.  Sub-Lethal Dose of Shiga Toxin 2 from Enterohemorrhagic Escherichia coli Affects Balance and Cerebellar Cytoarchitecture.

Authors:  Luciana D'Alessio; Alipio Pinto; Adriana Cangelosi; Patricia A Geoghegan; Carla Tironi-Farinati; Gabriela J Brener; Jorge Goldstein
Journal:  Front Microbiol       Date:  2016-02-10       Impact factor: 5.640

9.  Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome.

Authors:  Alexandra Kleimann; Sermin Toto; Christian K Eberlein; Jan T Kielstein; Stefan Bleich; Helge Frieling; Marcel Sieberer
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

Review 10.  Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.

Authors:  Lindsay S Keir; Stephen D Marks; Jon Jin Kim
Journal:  Drug Des Devel Ther       Date:  2012-07-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.